DNA isolated from biopsies of endemic Burkitt's lymphoma (BL) from New Guinea was analysed for the presence of Epstein-Barr virus (EBV) sequences using the polymerase chain reaction. Primers were designed to amplify sequences within the Epstein-Barr virus nuclear antigen (EBNA) 1 and 2 genes. These analyses detected the EBNA1 sequence in all the biopsies studied. 
Introduction
Epstein-Barr virus (EBV) is a herpesvirus with a DNA genome of approximately 172000 base pairs. Worldwide, the virus infects more than 90 % of the human population, and at any moment a large proportion of these individuals are shedding virus from sites from which the virus can easily spread to other individuals. The pronounced tropism of EBV for B lymphocytes is reflected in its association with three lymphoproliferative diseases of B cell origin: acute infectious mononucleosis, endemic Burkitt's lymphoma (BL) and lymphomas in immunocompromised individuals. In addition, in vitro infection of B lymphocytes with EBV leads to their immortalization, and in vivo EBV-infected B lymphocytes are capable of spontaneous outgrowth when cultured. In EBV-immortalized cells the entire EBV genome is maintained as a plasmid at a constant copy number and its expression is reduced to the few genes that define latency; these encode two small RNAs, the Epstein-Barr nuclear antigens (EBNAs), the latent membrane protein (LMP), the leader protein (LP) (Miller, 1985) , the BHRFl-encoded product (Bodescot et al., 1986; Pfitzner et al., 1987) and the terminal proteins (TP1 and TP2) (Laux et al., 1988) .
EBV strains can be categorized into one of two types (A-type or B-type) which show sequence divergence within their BamHI WYH and HindIII E gene regions reflecting divergence in the EBNA2, 3, 4 and 6 gene products (Adldinger et al., 1985, Dambaugh et al., t984; Sculley et al., 1989; Sample et al., 1990) . Differences in these proteins, expressed during EBV-induced transformation of B lymphocytes, are reflected in biological differences between A-type and B-type EBV. The most significant changes are a reduction in the efficiency of transformation, making the establishment of B-type EBV cell lines difficult, and altered phenotypes in the emerging transformed cells (Rowe et al., 1989) . The geographical distribution of these two virus types may also be different with the B-type virus having been identified in individuals living in endemic malarial regions of Africa and New Guinea (Ernberg et al., 1986; Zimber et al., 1986; Young et at., 1987; Sculley et al., 1988; Rowe et al., 1989) . The present study was undertaken to determine the frequency of B-type EBV in BL from New Guinea and to ascertain whether EBV strains (both A-type and B-type) in New Guinea are different from those found in Africa. in endemic malarial regions of either Africa (Kenya) or New Guinea (lowlands) ( Table 1 ). The WAN-BL line was established from an African (Kenya) BL biopsy (Young et al., 1987) . The B95-8 line was used as a source of the prototype A-type virus (Baer et al., 1984) and the Ag876 line was used as a source of prototype B-type virus (Dambaugh et al., 1984) .
Preparation of DNA from paraffin sections. The procedure used was a modification of that described by Impraim et al. (1987) . Essentially, twenty-five 4 gm sections were deparaffinized with Histene and each sample was then treated extensively with Proteinase K. The sample was then extracted with phenol, treated with RNase and the DNA was recovered by ethanol precipitation.
Polymerase chain reaction. EBNA1 primers were used to detect the presence of EBV in each BL biopsy. The EBNA1 primer sequences were as follows: (1.1) 5' TGACGTGCCCCCGGGAGCGA 3' (1109230 to 109249); (1.2) 5'TTCCGCCTGCCTCCATCACCY (109309 to 109328). Primers designed to distinguish between A-type and B-type EBV were targeted to the EBNA2 gene region of EBV ( Fig.  1) (Baer et al., 1984; Dambaugh et al., 1984) . The sequences of primers were derived from the published sequences of B95-8 (A-type) and Ag876 (B-type). The A-type primer sequences, with B95-8 coordinates, PCR-amplified products were identified on Southern blots using an [~-32P]dCTP-labelled probe generated by PCR using the same primers and either the purified M-ABA BamHI insert from pM-Bam H2 (A-type) (Polack et al., 1984) , the purified M-ABA BglII C insert from pMB2C (Polack et al., 1984) (for 2.5/2.6 primers) or the purified Jijoye BamHI/PstI insert from pJ-HKA7 (B-type) (Adldinger et al., 1985) as templates. For the preparation of probe, dCTP was replaced by [32P]dCTP (50 gCi, 0.167 mM) in the PCR reaction and 25 ng of each insert was used as template. Radiolabelled probes prepared in this manner had very high specific activities and increased the sensitivity of the detection system when compared with using end-labelled synthetic oligonucleotides as probes. Primers used for the amplification of the EBNA2 gene for sequencing were designed to be complementary to regions of the EBNA2 gene which are conserved between the A-type and B-type viruses and to flank the variable region targeted by the typespecific primers 2A. 1/2A. 2 and 2B. 1/2B. 2 (see above). The sequences of these primers were as follows: ($2.1) 5' AGGGATGCCTGGACA-CAAGA3' (B95-8 48819 to 48838; Ag876 1740 to 1759): ($2.2) 5' TGTGCTGGTGCTGCTGGTGG 3' (B95-8 49420 to 49401; Ag876 2314 to 2295).
The PCR was carried out in a 100 gl volume containing 10 mMTri~HC1 pH 8"3, 50 mM-KC1, 1"5 mM-MgC12, 0.001% (w/v) gelatin, 0.188 mM-dATP, dCTP, dGTP and TTP, l gM of each oligonucleotide primer and 2.5 units of Taq polymerase (Perkin-Elmer). For the amplification of template prepared from whole cells between 10 and 100 ng of DNA was added to this reaction mixture. The reaction mixture was overlaid with mineral oil and amplified in a DNA thermal cycler (Perkin-Elmer). The template was denatured for 2 min at 94 °C then put through 25 (or 35) cycles consisting of 1 min at 94 °C, 2 min at 55 °C for reannealing and 30 s at 72 °C for extension. To amplify DNA for sequencing with the $2.1/$2.2 primers, the conditions were 1 min at 94 °C, 2 rain at 65 °C for reannealing and 1 min at 72 °C for extension for 35 cycles.
Cloning of DNA for sequenc#1g. The PCR-amplified region of EBNA2 generated with the primer set $2.1/$2.2 was electrophoresed on 1.2% agarose gels (SeaKem, FMC Bioproducts), excised and purified using Geneclean (Bresatec). The DNA was then blunt-ended and cloned into Sinai-cut pUC19 (Yanisch-Perron et al., 1985) as described in Sambrook et al. (1989) . The ligation mixture was transformed into Escherichia coli SURE (Stratagene) using electroporation (Gene Pulser; Bio-Rad) under conditions described by Dower et al. (1988) . Colonies were selected on Luria broth agar (1.5 %) using ampicillin (100 lag/ml) and tetracycline (15 gg/ml). The agar plates were pretreated with 40 gl X-Gal (2% w/v) and 4 ~tl IPTG (100 mM) per plate as described in Sambrook et al. (1989) for blue/white colony selection. Large-scale isolation of plasmid DNA was performed using the alkaline lysis method (Sambrook et al., 1989) and DNA was purified using Qiagen columns (Diagen).
Sequencing. Double-stranded plasmid sequencing using [7-32P]ATP (5000 Ci/mmol) (Amersham) end-labelled primers was performed using the TaqTrack Deaza Sequencing System (Promega). Aliquots from the sequencing reactions were electrophoresed on 6 % acrylamide gels containing 7 M-urea at 60 V/cm using a Sequi-Gen Sequencing Gel apparatus (Bio-Rad). Nucleotide sequence was obtained from both 1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16 17  18  19 20 Q Fig, 2 . Typing of EB¥ present in paraffin-embedded BL biopsies from Papua New Guinea by PCR amplification. DNA was extracted from the biopsies and subjected to PCR amplification using primers complementary to regions within the EBNA2A and EBNA2B genes. The amplified products were separated on 4.0 % Nusieve agarose gels and identified by Southern blot analysis using either an EBNA2A-specific ~a) or an EBNA2B-specific radiolabelled probe (b 
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Identification of A-type and B-type EBV in BL biopsies
DNA was isolated from 56 paraffin-embedded formalinfixed BL biopsies originating from patients in New Guinea. PCR was used, employing primers targeted to the EBNA1 gene, to demonstrate the presence of EBV in these samples. All of the biopsy samples were positive for the presence of EBNA1 gene sequence (results not shown). The type of EBV present in these samples was determined using primers (2A. 1/2A. 2 and 2B. 1/2B. 2) directed against a region of the EBNA2 gene that showed DNA sequence divergence between the two EBV types. Using these primers, EBV could be typed in only 77 % (43/56) of the biopsy samples. Of the biopsies that could be typed 47 % (20/43) were A-type, 51% (22/43) B-type and one sample contained both A-type and B-type sequences. Fig. 2 shows the results obtained with 18 of the samples and these are representative of all the results obtained. Samples 3 and 13 were negative, samples 5, 7, 9 to 12, 14, 16 and 18 were A-type and samples 4, 6, 8, 15, 17, 19 and 20 were B-type. Primers (2A.3/2A.4 and 2B.3/2B.4) directed to another region of the EBNA2 gene, which also shows high sequence variability between the A-and B-type virus, were used in an attempt to type the 13 remaining negative samples. Using these primers, five of the samples could be typed with two being A-type, two B-type and one sample positive for both A-and B-types. The remaining eight untyped samples were PCR-amplified using universal primers (2.5/2.6) directed against a different region of the EBNA2 gene. Using these primers an additional five samples were typed; four were B-type and one contained both A-and B-type sequences. Three samples remained untypeable by all three sets of EBNA2-derived primers.
The inability to determine the EBV type in 23 % (13/56) of the samples using the 2A.1/2A.2 and 2B.1/2B.2 primers was surprising since EBNA2 sequences (in 10 of the samples) and EBNA1 sequences (in all samples) were amplifiable using alternative primers. This suggested that lack of intact template due to DNA degradation was unlikely to be the problem. Another possibility was that of DNA sequence variation within the EBNA2 gene in EBV strains in New Guinea. Changes in the DNA sequence within the EBNA2 gene could preclude the binding of these primers and explain the inability to amplify by PCR and to type the EBV strains in all of the samples using one set of primers.
Sequencing of A-type and B-tyTe EBV strains from Africa and New Guinea
To investigate the possibility that EBV strains from New Guinea exhibit DNA sequence divergence within the EBNA2 gene, PCR primers designed to amplify both Atype and B-type sequence over the region targeted by our type-specific primers were prepared. The degree of degradation of the DNA obtained from the New Guinea BL biopsy specimens precluded the use of these samples to obtain PCR fragments suitable for sequencing. The primers were therefore used to amplify and to sequence regions from A-and B-type EBV spontaneous lymphoblastoid cell lines originating from individuals living in areas endemic for BL in Africa and New Guinea. These primers amplified a 602 bp fragment in B95-8 and a 575 bp fragment in Ag876. These primers were used in PCR to amplify DNA from cell lines containing EBV strains originating from either New Guinea or Africa. 
Asn Asn * The numbering of the nucleotide sequences is consistent with that used in Cohen et al. (1991) .
~" Fifty-one base pair deletion relative to B95-8. :~ Extra three nucleotides relative to B95-8.
The resultant amplified DNA was purified from agarose gels and cloned into pUC19. Sequencing of the cloned fragments from the A-type strains showed that the New Guinea strains L3 and L8 had a 51 bp deletion relative to B95-8 in this region of the EBNA2 gene (between nucleotides 586 and 638) ( Table  2 ). L3 had a further 11 nucleotide mismatches with the B95-8 sequence which resulted in seven predicted amino acid (aa) changes. L8 shared nine of these sequence mismatches, resulting in seven predicted aa changes in common in these two strains. The two African strains, FWA and ODH, also share nine sequence differences from B95-8. These common sequence mismatches result in six predicted aa changes from the B95-8 EBNA2 protein. The ODH and FWA sequences had a 3 bp insertion between nucleotides 633 and 634 relative to B95-8 which results in the insertion of an extra Leu 299
* The numbering of the nucleotide sequences is consistent with that used in Cohen et al. (1991) . residue in the EBNA2 protein sequence. Of the nine sequence mismatches common to both the ODH and FWA strains, only three were present in the New Guinea strains L3 and L8.
The sequencing of this region of EBNA2 from the Btype virus strains revealed less variation than was found amongst the A-type strains (Table 3) . L4 had only three nucleotide mismatches resulting in three predicted aa changes in the EBNA2 protein sequence compared with Ag876; two of these were also found in the other New Guinea strain L19. L19 had a further two nucleotide mismatches compared to Ag876, both of which would result in predicted aa changes. The B-type virus strains from Africa, ALU and WAN-BL, had one nucleotide mismatch compared to Ag876, resulting in one predicted aa change.
Discussion
Previous studies carried out on BL biopsies from endemic regions of Africa demonstrated that more than 95% carried EBV (Geser et al., 1983) . Typing of the EBV present in African BL biopsies revealed about a third to be infected with B-type EBV (Zimber et al., 1986; Young et al., 1987) . In order to investigate the prevalence of Btype EBV in BLs from other BL endemic areas we have assayed the EBV types present in BL biopsies originating from endemic regions of New Guinea. PCR analyses of New Guinea BL biopsies revealed the presence of EBV in all of the samples, consistent with the results from the African BLs. However, the type of EBV present in the New Guinea BL biopsies could be determined in only 77 % (43/56) of the samples using our original primers.
Using alternative sets of primers directed against the EBNA2 gene we were able to type 95 % (53/56) of the samples. Overall 39 % (22/56) were A-type, 50 % (28/56) were B-type, 5 % (3/56) appeared to contain both A-and B-type sequences and 5 % (3/56) remained untypeable. The three samples that remained negative in terms of the detection of EBNA2 sequences may well have been deleted for this region because, unlike EBNA1, EBNA2 expression is unnecessary for the maintenance of the virus in BL cell lines (Bornkamm et al., 1982; Zimber et al., 1986) .
The typing of the BL paraffin sections revealed a predominance of B-type strains. It is not clear whether this indicates an association of B-type EBV with BL or if it is a reflection of the distribution of the virus types in the New Guinea population. The result is consistent with the relatively high proportion of B-type EBV strains detected in African BLs (Zimber et al., 1986; Young et al., 1987) . The other interesting result was the presence of both A-and B-type sequences in three of the samples. This was unexpected as BLs are clonally derived and should exhibit the presence of only one type of virus, unless the progenitor cell was dually infected. The issue of dual infection as opposed to the strict clonality of BL tumours could not be resolved using paraffin-embedded tissue and therefore remains an open question.
The inability to type all of the New Guinea BL biopsies using the original type-specific primers (2A. 1/2A.2 and 2B. 1/2B.2) was unlikely to be due to degradation of the samples since EBNA1 sequences could be PCR-amplified and 10/13 of the samples could be typed using alternative Et~NA2 primers. One possibility was divergence in the EBNA2 DNA sequences in New Guinea EBV isolates resulting in inefficient binding of primers in the PCR. Little is known about the extent of sequence divergence between different strains of EBV. The A-type B95-8 is the only strain that has been completely sequenced (Baer et al., 1984) . The EBNA2 gene region has been sequenced in one other A-type strain, W91 (Cohen et al., 1991) , and two B-type strains, Jijoye and Ag876 (Dambaugh et al., 1984; Dillner & Kallin, 1988) . B95-8 and W91 were found to have 97.4 % sequence identity in this region; Ag876 and Jijoye were also very similar, having identical predicted amino acid sequences for EBNA2 (Dillner & Kallin, 1988) .
To determine the degree of sequence divergence in New Guinea EBV strains PCR primers were designed to flank the type-specific primers (2A.1/2A.2 and 2B. 1/2B.2) targeted to the EBNA2 gene region. The DNA sequences obtained from the African and New Guinea lines showed a number of substitution, insertion and deletion mutations relative to the published sequences of B95-8 and Ag876. A single nucleotide mismatch was found in the B-type strains ALU and WAN-BL in the region in which one of the B-type specific primers binds (2B. 1) and in L3 within the region in which the A-type primer 2A. 1 binds (Fig. 2, Tables 2  and 3 ). This type of DNA sequence variation in different strains of EBV supports the possibility that inefficient binding of PCR primers, which are based on the prototype EBV sequences, may occur preventing amplification and detection of EBV DNA sequences.
Comparing the DNA sequence variation within the Atype strains it was apparent that the strains fell into two groups. The New Guinea strains L3 and L8 were closely related and differed significantly from the two African strains ODH and FWA (Table 2 ). This grouping is compatible with the geographical origins of the strains. This was also apparent from the sequences obtained from the B-type EBV strains (Table 3) , with the New Guinea isolates L4 and L19 showing a greater degree of relatedness to each other than to the African strains ALU, WAN-BL and Ag876.
All the A-type strains showed nucleotide sequence changes compared to the B95-8 strain. Many of these changes are also found in the published sequence of the W91 virus strain (derived from an African endemic BL cell line) (Cohen et at., 1991) . The A-type strains and W91 share nucleotide changes at positions 487/488, 495 and 554 relative to the B95-8 sequence ( Table 2 ). The African strains FWA and ODH also have the same mismatches as the W91 strain at nucleotide positions 588, 610 and 667 and the same 3 bp insertion (coding for an additional Leu residue) between nucleotides 633 and 634 of B95-8. Although there are marked differences between the African and New Guinea strains they appeared to be more similar to each other than to B95-8.
The deletion found in the A-type strains L3 and L8 from New Guinea (between nucleotides 586 and 638) (Table 2) removes one copy of a 51 bp direct repeat. This deletion would not be expected to affect the transforming ability of these strains because a similar deletion in the W91 virus strain has revealed this region to be nonessential for transformation and trans-activation of LMP (Cohen et al., 1991) . The 51 bp deletion in these A-type strains is consistent with previous observations of apparent size variability in the EBNA2 protein (Young et al., 1987) .
We have identified DNA sequence heterogeneity, within the EBNA2 gene, among different strains of EBV. This variation in DNA sequence could explain the inability to type EBV strains, from many of the Papua New Guinea biopsies, using PCR primers based upon the published B95-8 EBNA2 sequence. Strains with a common geographical origin were found to be more similar to each other than to strains isolated from other regions. Therefore efficient PCR typing of EBV strains may require the use of PCR primers designed from sequence information obtained from isolates from the same geographical areas.
